Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InMed Pharmaceuticals (INM)
NASDAQ:INM
Holding INM?
Track your performance easily
INM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.41 - $15.69
Previous Close$4.59
Volume8.58K
Average Volume (3M)40.01K
Market Cap
$3.32M
Enterprise Value-$1.24M
Total Cash (Recent Filing)$5.63M
Total Debt (Recent Filing)$1.06M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Feb 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.34
Shares Outstanding667,672
10 Day Avg. Volume18,952
30 Day Avg. Volume40,006
Standard Deviation0.26
R-Squared0.02
Alpha-0.08
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.38
Price to Sales (P/S)0.62
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-0.25
Enterprise Value/Gross Profit-1.13
Enterprise Value/Ebitda0.20
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InMed Pharmaceuticals News
PremiumCompany Announcements
InMed Pharmaceuticals’ 2024 AGM Results Announced
PremiumCompany Announcements
InMed Pharmaceuticals Secures $10 Million Equity Purchase Agreement
PremiumCompany Announcements
InMed Pharmaceuticals Explores CBN for Skin Disease Treatment
PremiumCompany Announcements
InMed’s Study Highlights Cannabinol’s Potential in Skincare
PremiumCompany Announcements
InMed Pharmaceuticals Reports Improved Quarterly Earnings
PremiumCompany Announcements
InMed Pharmaceuticals Makes Progress on Alzheimer’s Drug
Ownership Overview
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
INM FAQ
What was InMed Pharmaceuticals’s price range in the past 12 months?
InMed Pharmaceuticals lowest stock price was $2.41 and its highest was $15.69 in the past 12 months.
What is InMed Pharmaceuticals’s market cap?
Currently, no data Available
When is InMed Pharmaceuticals’s upcoming earnings report date?
InMed Pharmaceuticals’s upcoming earnings report date is Feb 18, 2025 which is in 52 days.
How were InMed Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is InMed Pharmaceuticals overvalued?
According to Wall Street analysts InMed Pharmaceuticals’s price is currently Overvalued.
Does InMed Pharmaceuticals pay dividends?
InMed Pharmaceuticals does not currently pay dividends.
What is InMed Pharmaceuticals’s EPS estimate?
InMed Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InMed Pharmaceuticals have?
InMed Pharmaceuticals has 724,152 shares outstanding.
What happened to InMed Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of InMed Pharmaceuticals?
Currently, no hedge funds are holding shares in INM
---
Company Description
InMed Pharmaceuticals
InMed Pharmaceuticals, Inc. engages in the research and development of cannabinoid-based therapies and biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids. It offers pipeline of medications that target diseases with unmet medical needs, such as epidermolysis bullosa, glaucoma, and orofacial pain. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
---
Technical Analysis
AXIM Biotechnologies
―
Corbus Pharmaceuticals
―
Outlook Therapeutics
―
Sorrento Therapeutics
―
---